The Critical Path for Alzheimer’s Disease (CPAD) Consortium: A platform for pre‐competitive data sharing, standardization, and analysis to support quantitative tools for AD drug development

MLA

Sudhir Sivakumaran, et al. “The Critical Path for Alzheimer’s Disease (CPAD) Consortium: A Platform for Pre‐competitive Data Sharing, Standardization, and Analysis to Support Quantitative Tools for AD Drug Development.” Alzheimer’s & Dementia, vol. 17, Dec. 2021. EBSCOhost, https://doi.org/10.1002/alz.051903.

APA

Sudhir Sivakumaran, Nathan J Hanan, Zihan Cui, Jackson Burton, Patrick Lang, Eileen Priest, Hazel White, Klaus Romero, & Yashmin Karten. (2021). The Critical Path for Alzheimer’s Disease (CPAD) Consortium: A platform for pre‐competitive data sharing, standardization, and analysis to support quantitative tools for AD drug development. Alzheimer’s & Dementia, 17. https://doi.org/10.1002/alz.051903

Chicago

Sudhir Sivakumaran, Nathan J Hanan, Zihan Cui, Jackson Burton, Patrick Lang, Eileen Priest, Hazel White, Klaus Romero, and Yashmin Karten. 2021. “The Critical Path for Alzheimer’s Disease (CPAD) Consortium: A Platform for Pre‐competitive Data Sharing, Standardization, and Analysis to Support Quantitative Tools for AD Drug Development.” Alzheimer’s & Dementia 17 (December). doi:10.1002/alz.051903.